07:00 , Oct 30, 2008 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Endocrine disease ...
07:00 , Oct 30, 2008 |  BC Innovations  |  Targets & Mechanisms

Block JNK at the dock

A team of U.S. researchers has described a new mitogen-activated protein kinase 8 (JNK; MAPK8) inhibitor that targets JNK's substrate docking site-instead of its ATP binding site-to treat type 2 diabetes.1 The targeting strategy should...